首页> 外文期刊>Science >Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF(high) neutrophils
【24h】

Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF(high) neutrophils

机译:成骨细胞远程为肺癌提供促癌的SiglecF(高)中性粒细胞

获取原文
获取原文并翻译 | 示例
       

摘要

Bone marrow-derived myeloid cells can accumulate within tumors and foster cancer outgrowth. Local immune-neoplastic interactions have been intensively investigated, but the contribution of the systemic host environment to tumor growth remains poorly understood. Here, we show in mice and cancer patients (n = 70) that lung adenocarcinomas increase bone stromal activity in the absence of bone metastasis. Animal studies reveal that the cancer-induced bone phenotype involves bone-resident osteocalcin-expressing (Ocn(+)) osteoblastic cells. These cells promote cancer by remotely supplying a distinct subset of tumor-infiltrating SiglecF(high) neutrophils, which exhibit cancer-promoting properties. Experimentally reducing Ocn(+) cell numbers suppresses the neutrophil response and lung tumor outgrowth. These observations posit osteoblasts as remote regulators of lung cancer and identify SiglecF(high) neutrophils as myeloid cell effectors of the osteoblast-driven protumoral response.
机译:骨髓来源的髓样细胞可以在肿瘤内积累并促进癌症的生长。局部免疫-肿瘤相互作用已得到深入研究,但全身宿主环境对肿瘤生长的贡献仍知之甚少。在这里,我们在小鼠和癌症患者(n = 70)中显示,在没有骨转移的情况下,肺腺癌会增加骨基质的活性。动物研究表明,癌症诱发的骨表型涉及骨驻骨表达骨钙蛋白(Ocn(+))的成骨细胞。这些细胞通过远程提供肿瘤浸润的SiglecF(高)中性粒细胞的不同子集来促进癌症,这些子集具有促进癌症的特性。实验上减少Ocn(+)细胞数量可抑制嗜中性粒细胞反应和肺肿瘤的生长。这些观察结果将成骨细胞定位为肺癌的远程调节剂,并将SiglecF(高)中性粒细胞鉴定为成骨细胞驱动的前列腺反应的髓样细胞效应子。

著录项

  • 来源
    《Science》 |2017年第6367期|1147-1147|共1页
  • 作者单位

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA|Harvard Med Sch, Grad Program Immunol, Boston, MA 02115 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA|Vilnius Univ, Inst Biotechnol, LT-10257 Vilnius, Lithuania;

    Harvard Med Sch, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA;

    Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA;

    Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland;

    Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA;

    Harvard Med Sch, Grad Program Immunol, Boston, MA 02115 USA|Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA|Harvard Med Sch, Grad Program Immunol, Boston, MA 02115 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA|Harvard Med Sch, Grad Program Immunol, Boston, MA 02115 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA|Harvard Med Sch, Grad Program Immunol, Boston, MA 02115 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA;

    Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland;

    MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA;

    Harvard Med Sch, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA;

    Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA;

    Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA|Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA|Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA;

    Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA|Harvard Med Sch, Boston, MA 02114 USA|Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:51:24

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号